Covetrus Inc
NASDAQ:CVET
Covetrus Inc
NASDAQ:CVET
Price:
20.99 USD
Market Closed
Updated:
May 1, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of CVET.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CVET
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
CVET Competitors Multiples
Covetrus Inc Competitors
Covetrus Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Covetrus Inc
NASDAQ:CVET
|
2.9B USD | 0.6 | -225.8 | 23.2 | -3 831.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
70.4B USD | 0.2 | 23.5 | 16.3 | 18.9 | |
| US |
|
Cencora Inc
NYSE:COR
|
47.7B USD | 0.2 | 25.5 | 13.1 | 18.4 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
25.1B USD | 0.1 | 39.3 | 8.8 | 11.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 0.7 | 21.5 | 11.4 | 15.3 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 1.4 | 21.3 | 15.5 | 15.5 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
61.9B HKD | 0.1 | 6.4 | 1.5 | 1.8 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.1B EUR | 3.1 | 45.7 | 14.8 | 29.1 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.2 | 13.5 | 8 | 8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
